Weaver Consulting Group’s GW Pharmaceuticals Plc American Depositary Shares GWPH Stock Holding History

Weaver Consulting Group’s Portfolio GWPH Stock Details GWPH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-157	Closed	-$15K	–	1001
2020 Q3	$15K	Sell	157 -150	-49%	-$17.3K	0.01%	469
2020 Q2	$38K	Hold	307	–	–	0.02%	294
2020 Q1	$27K	Sell	307 -50	-14%	-$5.29K	0.02%	292
2019 Q4	$41K	Hold	357	–	–	0.02%	263
2019 Q3	$59K	Hold	357	–	–	0.03%	212
2019 Q2	$62K	Hold	357	–	–	0.03%	200
2019 Q1	$62K	Buy	+357	New	+$53.1K	0.02%	425

Other funds holding GWPH

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

EMG

ETF Managers Group Summit, New Jersey $3.1B AUM 17.12% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Weaver Consulting Group's GWPH Position: Q4 2020 in Review

Weaver Consulting Group sold out of GW Pharmaceuticals Plc American Depositary Shares (GWPH) in Q4 2020, closing a stake of 157 shares — an estimated $15K sold.

Weaver Consulting Group first reported a position in GWPH in Q1 2019 and held it in 7 quarters. The position peaked at $62K in Q2 2019. 279 funds tracked by Wall St. Rank hold GWPH as of Q4 2020.

Weaver Consulting Group reported no remaining GW Pharmaceuticals Plc American Depositary Shares position as of Q4 2020 after selling out during the quarter.
Weaver Consulting Group sold 157 GW Pharmaceuticals Plc American Depositary Shares shares in Q4 2020, an estimated $15K.
Weaver Consulting Group first reported a position in GW Pharmaceuticals Plc American Depositary Shares in Q1 2019 and held it in 7 quarters.
Weaver Consulting Group's GW Pharmaceuticals Plc American Depositary Shares position peaked at $62K in Q2 2019.
279 funds tracked by Wall St. Rank held GW Pharmaceuticals Plc American Depositary Shares as of Q4 2020.

Based on Weaver Consulting Group's 13F filing for Q4 2020, filed 29 Jan 2021.